COVID-19’s impact on bioanalytical labs

COVID-19’s impact on bioanalytical labs

One year later, the impact of the COVID-19 pandemic on business practices, supply chains, timelines and analytical needs for COVID-19 clinical trials have been felt across the bioanalytical community, as therapeutics may now require SARS-CoV-2 antigen and serological testing.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioanalysis 2021-08, Vol.13 (15), p.1169-1171
Hauptverfasser: Lavelle, Amy, Micheli, Janine
Format: Artikel
Sprache:eng
Schlagworte:
bioanalysis
clinical trials
COVID-19
NAAT
SARS-CoV-2 antigen
serology
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:One year later, the impact of the COVID-19 pandemic on business practices, supply chains, timelines and analytical needs for COVID-19 clinical trials have been felt across the bioanalytical community, as therapeutics may now require SARS-CoV-2 antigen and serological testing.
ISSN:1757-6180
1757-6199
DOI:10.4155/bio-2021-0103